Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BCEL

Atreca (BCEL) Stock Price, News & Analysis

Atreca logo

About Atreca Stock (NASDAQ:BCEL)

Advanced Chart

Key Stats

Today's Range
$0.09
$0.09
50-Day Range
$0.09
$0.09
52-Week Range
$0.05
$1.20
Volume
N/A
Average Volume
4.61 million shs
Market Capitalization
$3.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atreca and its competitors with MarketBeat's FREE daily newsletter.

BCEL Stock News Headlines

Bicycle Therapeutics Is Looking Increasingly Attractive
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Atreca, Inc. (0C1.MU)
Atreca Inc. Cl A
Atreca Stock (NASDAQ:BCEL), Short Interest Report
See More Headlines

BCEL Stock Analysis - Frequently Asked Questions

Atreca, Inc. (NASDAQ:BCEL) released its quarterly earnings results on Tuesday, November, 2nd. The company reported ($0.74) EPS for the quarter, hitting analysts' consensus estimates of ($0.74).

Atreca (BCEL) raised $126 million in an initial public offering on Thursday, June 20th 2019. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. Cowen, Evercore ISI and Stifel acted as the underwriters for the IPO and Canaccord Genuity and Brookline Capital Markets were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Atreca investors own include Editas Medicine (EDIT), NVIDIA (NVDA), Micron Technology (MU), Alector (ALEC), Advanced Micro Devices (AMD), PayPal (PYPL) and Meta Platforms (META).

Company Calendar

Last Earnings
11/02/2021
Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BCEL
Fax
N/A
Employees
130
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$97.16 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$2.01 per share
Price / Book
0.04

Miscellaneous

Free Float
35,146,000
Market Cap
$3.57 million
Optionable
Optionable
Beta
1.03
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:BCEL) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners